Publication:
Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey

Simple item page
dc.contributor.authorTÜREL, Özden
dc.contributor.authorKisa, Adnan
dc.contributor.authorMcIntosh, E. David G.
dc.contributor.authorBakir, Mustafa
dc.contributor.institutionauthorTÜREL, ÖZDEN
dc.date.accessioned2020-10-22T19:25:03Z
dc.date.available2020-10-22T19:25:03Z
dc.date.issued2013-07-01T00:00:00Z
dc.description.abstractBackground: Pneumococcal infection is an important and preventable cause of morbidity and mortality. The Turkish government introduced 7-valent pneumococcal conjugate vaccine (PCV) into the national immunization program in 2009. This suggests that replacing 7-valent PCV with a higher-valent version could at least maintain -standard of care- if not improve it, and that it could be affordable. Objectives and Methods: The aim of this analysis was to assess the potential direct cost-effectiveness of 13-valent PCV in Turkey, a country with a birth cohort of 1.4 million, against a -no vaccine- state, against the default 7-valent PCV state, and against a 10-valent PCV state, using a published cohort model with a 5-year horizon. Results and Conclusions: The cost per life-year gained is below the 1 x per-capita gross domestic product threshold across large changes in key input parameters, indicating that the model is stable and suggesting that any PCV would be very cost-effective in a Turkish national pediatric immunization schedule.
dc.identifier.citationTÜREL Ö., Kisa A., McIntosh E. D. G. , Bakir M., -Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey-, VALUE IN HEALTH, cilt.16, ss.755-759, 2013
dc.identifier.doi10.1016/j.jval.2013.03.1632
dc.identifier.pubmed23947968
dc.identifier.scopus84881663984
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24469
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S109830151301810X?via%3Dihub
dc.identifier.wosWOS:000325466600008
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectVaccine
dc.titlePotential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey
dc.typeArticle
dspace.entity.typePublication
local.avesis.idba52771c-0f47-4a47-92e8-6c42ffdd6f0e
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublicationfe4466b2-6cba-4c75-af61-11128a0a945e
relation.isAuthorOfPublication.latestForDiscoveryfe4466b2-6cba-4c75-af61-11128a0a945e
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s2.0-S109830151301810X-main.pdf
Size:
317.56 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler